购物车
- 全部删除
- 您的购物车当前为空
Drp1 peptide inhibitor P110(Compound P110)作为一种选择性Drp1肽抑制剂,显示出显著的神经保护效果。该化合物能有效抑制Drp1活性,阻止由MPTP诱导的Drp1线粒体定位改变,并有助于减轻由MPTP引起的多巴胺能神经元损失、神经末梢损伤及行为缺陷,适用于阿尔兹海默症研究。此外,Compound P110在治疗亨廷顿病、脑缺血损伤及心肌梗死动物模型中,也能显著减轻线粒体及器官损伤。
Drp1 peptide inhibitor P110(Compound P110)作为一种选择性Drp1肽抑制剂,显示出显著的神经保护效果。该化合物能有效抑制Drp1活性,阻止由MPTP诱导的Drp1线粒体定位改变,并有助于减轻由MPTP引起的多巴胺能神经元损失、神经末梢损伤及行为缺陷,适用于阿尔兹海默症研究。此外,Compound P110在治疗亨廷顿病、脑缺血损伤及心肌梗死动物模型中,也能显著减轻线粒体及器官损伤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | Compound P110 (Drp1 peptide inhibitor P110) is a selective Drp1 peptide inhibitor with neuroprotective effects. It inhibits the activation of Drp1, prevents Drp1 mitochondrial translocation induced by MPTP, and alleviates dopamine neuron loss, dopaminergic terminal damage, and behavioral deficits caused by MPTP. This compound is useful for Alzheimer’s disease research. Additionally, Compound P110 reduces mitochondrial and organ damage in animal models of Huntington's disease, cerebral ischemia, and myocardial infarction. |
分子量 | 2411.78 |
分子式 | C100H179N45O25 |
CAS No. | 2770267-63-3 |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容